IFPMA Outlines Plan For Fighting Counterfeit Drugs
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - The threat of counterfeit anti-infective drugs is rising rapidly, even as pharmaceutical companies, regulators and industry associations develop new strategies to deal with the problem